STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Datavault AI Inc Stock Price, News & Analysis

DVLT Nasdaq

Welcome to our dedicated page for Datavault AI news (Ticker: DVLT), a resource for investors and traders seeking the latest updates and insights on Datavault AI stock.

Datavault AI Inc (DVLT) combines blockchain innovation with AI-driven data solutions and advanced acoustic technologies across multiple industries. This news hub provides investors and technology professionals with essential updates on the company's Web 3.0 developments, strategic partnerships, and market expansions.

Access real-time announcements about DVLT's data licensing platforms, digital twin implementations, and spatial audio advancements. Our curated collection includes earnings reports, technology patents, leadership updates, and cross-industry collaborations in biotech, energy, and entertainment sectors.

Discover how DVLT's dual focus on high-performance computing solutions and acoustic science innovations drives value creation. Regular updates cover tokenization progress, blockchain infrastructure enhancements, and licensing agreements through the ADIO and WiSA audio platforms.

Bookmark this page for streamlined access to verified DVLT developments. Monitor the company's progress in converting data assets into marketable products while maintaining leadership in both digital transformation and immersive audio experiences.

Rhea-AI Summary

Datavault AI (Nasdaq: DVLT) granted a worldwide exclusive license with sublicense rights to Scilex (Nasdaq: SCLX) for Datavault AI's AI-driven tokenization and data-monetization technology tailored to biotech and biopharma.

Key terms: a $10.0 million nonrefundable upfront license fee payable in four equal installments through Sept 30, 2026, plus up to $2.55 billion in sales milestone payments. The license covers tokenization of genomic/DNA data, diagnostics, therapeutics, genetic and drug information and cites an estimated $2.0 trillion tokenization opportunity in pharmaceutical and diagnostic sales.

The deal highlights Datavault AI's issued and pending patents, including a pending patent for tokenizing DNA data (U.S. App. No. 17/941,623), and builds on prior AI collaborations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.26%
Tags
AI
-
Rhea-AI Summary

Datavault AI (Nasdaq: DVLT) on November 3, 2025 announced a collaboration with NFHITS and Music Dash to build a Web 3.0 minting and blockchain-based music and content distribution network.

The partnership will integrate Datavault AI’s Datavalue, DataScore, Data Vault Bank, VerifyU, ADIO and NYIAX-powered exchange features to mint music assets, authenticate artists/rights, protect royalties, reduce piracy, and enable digital collectibles and objectified music assets across major platforms.

The companies plan to deploy inaudible ADIO tone delivery across venues and retail channels and leverage NFHITS’ existing distribution footprint to create new monetization streams for artists.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.36%
Tags
AI
-
Rhea-AI Summary

Datavault AI (NASDAQ: DVLT) announced a one-time distribution of the Dream Bowl 2026 Meme Coin to DVLT and Scilex shareholders of record on Nov. 14, 2025, subject to board approval. Tokens will be airdropped to Data Vault® wallets following final roster confirmations on or after Nov. 25, 2025. The Dream Bowl event is scheduled for Jan. 11, 2026 at AT&T Stadium in Dallas and will include college football, drone racing, and e-sports championships. Tokens include utility features such as immutable ownership, embedded ticketing, and exclusive event content.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.36%
Tags
AI
Rhea-AI Summary

Datavault AI (NASDAQ: DVLT) issued a formal rebuttal to a Wolfpack Research short report it calls false and defamatory, announcing retained counsel and intent to pursue litigation and regulatory remedies. The Company reaffirmed its strategic focus on a patent-backed technology stack for data tokenization, AI-driven valuation, inaudible audio signal tech, and enterprise monetization, citing more than 70 U.S. and international patents and recent commercial milestones including acquisitions, partnerships, product launches, and planned data-exchanges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.44%
Tags
AI
-
Rhea-AI Summary

Datavault AI (Nasdaq: DVLT) announced it has entered into a definitive agreement to acquire API Media in an all-cash transaction expected to close in December 2025. The deal keeps the API brand and aims to combine Datavault’s patented data tokenization and monetization technologies with API’s audio/visual and event-focused solutions.

The companies say the acquisition will expand Datavault’s AI-powered capabilities, broaden its recurring-revenue base, and enhance enterprise data activation, audience intelligence, and revenue analytics across global markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.52%
Tags
-
Rhea-AI Summary

Datavault AI (Nasdaq: DVLT) announced a definitive global licensing agreement with Nature's Miracle (OTCQB: NMHI) dated October 28, 2025 to license Datavault AI's patented Carbon Credit Tokenization System.

Under the deal Datavault AI will receive a $2,000,000 non-refundable license fee plus a 35% royalty on all gross revenue generated from the licensed technology. The license grants worldwide rights for the life of the listed patents and targets blockchain-powered carbon credit tokenization, VerifyU credentialing, and ADIO data monetization, with commercial focus in Asia including Japan, Taiwan, and South Korea.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.52%
Tags
AI
Rhea-AI Summary

Datavault AI (Nasdaq: DVLT) announced on October 27, 2025 the launch of two data unions: an Insurance Data Union partnering with the Independent Insurance Agents & Brokers of America (Big "I") and independent agents, and an Accounting Data Union partnering with the top two private accounting firms from each U.S. state.

The unions will tokenize anonymized insurance and accounting data using Datavault AI's patented technologies (including U.S. Patent Nos. 12,198,201, 11,315,150, and 11,593,515) and pending applications to enable wallet-based tokens, smart-contract payments, and scalable monetization. The company cites total addressable markets of $8 trillion insurance and $650 billion accounting as opportunity backdrops.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
AI
-
Rhea-AI Summary

DataVault AI (NASDAQ: DVLT) and Wellgistics Health (NASDAQ: WGRX) entered a SAAS smart‑contract services agreement to develop PharmacyChain™, a manufacturer‑to‑patient blockchain tracking and dispensing platform targeting the $639 billion prescription drug market. The companies expect to finalize a profit‑sharing license in Q4 2025 and begin beta testing in H1 2026. DataVault AI cites issued U.S. patents dated April 16, 2024; June 25, 2024; and September 24, 2024 that it says cover blockchain, token‑driven data monetization and related IP. Management cites early inbound interest from manufacturers, pharmacists and insurers and describes plans for opt‑in biometric/diagnostic data and utility token monetization to enable new revenue streams.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
AI
-
Rhea-AI Summary

Datavault AI (NASDAQ: DVLT) announced a strategic expansion on Oct 23, 2025 including a planned relocation of its corporate headquarters to downtown Philadelphia, the opening of a Center for AI and Quantum Computing Excellence at 9040 Roswell Road in Sandy Springs, Georgia, and international growth with a Quantum Computing & Digital Twin Embassy in Knightsbridge, London.

The Georgia center occupies 180,000 sq ft on 23 acres with 22,000‑sq‑ft floor plates and on‑site data centers; Beaverton remains operational to support Pacific Rim clients. The company noted recent deals, including a partnership for a Swiss Digital RWA Exchange and the acquisition of NYIAX and IP to access the Nasdaq framework for its planned International Elements Exchange™. The board expanded its advisory roster with two new members and pending additional appointments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.14%
Tags
management AI
Rhea-AI Summary

DataVault AI (NASDAQ: DVLT) and Wellgistics (NASDAQ: WGRX) announced a non-binding letter of intent on Oct 22, 2025 to integrate PharmacyChain™, a manufacturer-to-patient blockchain smart-contract system, into Wellgistics’ technology and physical infrastructure.

The partners envision a revenue-sharing model from pharmacy fees, aim to digitize prescription tracking across a $634.32 billion U.S. prescription drug market, and cite Wellgistics’ network of 6,500+ independent pharmacies and AI tools (HubRx AI, Einstein Rx AI, clinical decision support) as integration points. Implementation depends on definitive agreements and conditions; no assurance of completion or revenue is provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.42%
Tags
AI

FAQ

What is the current stock price of Datavault AI (DVLT)?

The current stock price of Datavault AI (DVLT) is $1.78 as of November 4, 2025.

What is the market cap of Datavault AI (DVLT)?

The market cap of Datavault AI (DVLT) is approximately 523.9M.
Datavault AI Inc

Nasdaq:DVLT

DVLT Rankings

DVLT Stock Data

523.88M
237.30M
39.05%
4.91%
6.97%
Software - Infrastructure
Semiconductors & Related Devices
Link
United States
BEAVERTON